Real‐world outcomes for neoadjuvant capecitabine versus infusional 5‐fluorouracil in the treatment of locally advanced rectal cancer

Author:

Loft Matthew12ORCID,Wong Hui‐Li123,Kosmider Suzanne4,Lee Margaret1245,Tie Jeanne1234,Wong Rachel156ORCID,Jones Ian T.78,Croxford Matthew9,Steel Malcolm10,Faragher Ian9,Guerrieri Mario11,Christie Michael112,Gibbs Peter124

Affiliation:

1. Division of Personalised Oncology Walter and Eliza Hall Melbourne Victoria Australia

2. Department of Medical Biology University of Melbourne Melbourne Victoria Australia

3. Department of Medical Oncology Peter MacCallum Cancer Centre Melbourne Victoria Australia

4. Department of Medical Oncology Western Health Melbourne Victoria Australia

5. Department of Medical Oncology Eastern Health Melbourne Victoria Australia

6. Eastern Health Clinical School Monash University Melbourne Victoria Australia

7. Department of Colorectal Surgery Royal Melbourne Hospital Melbourne Victoria Australia

8. Department of Surgery University of Melbourne Melbourne Victoria Australia

9. Department of Colorectal Surgery Western Health Melbourne Victoria Australia

10. Department of Colorectal Surgery Eastern Health Melbourne Victoria Australia

11. GenesisCare Melbourne Victoria Australia

12. Department of Pathology Royal Melbourne Hospital Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Author reply;Internal Medicine Journal;2021-08

2. Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms;Internal Medicine Journal;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3